1. Home
  2. TXRH vs BMRN Comparison

TXRH vs BMRN Comparison

Compare TXRH & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Texas Roadhouse Inc.

TXRH

Texas Roadhouse Inc.

HOLD

Current Price

$168.86

Market Cap

11.0B

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$53.06

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXRH
BMRN
Founded
1993
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
10.5B
IPO Year
2004
1999

Fundamental Metrics

Financial Performance
Metric
TXRH
BMRN
Price
$168.86
$53.06
Analyst Decision
Buy
Buy
Analyst Count
17
19
Target Price
$189.47
$88.42
AVG Volume (30 Days)
824.9K
2.9M
Earning Date
11-06-2025
10-27-2025
Dividend Yield
1.62%
N/A
EPS Growth
12.56
59.53
EPS
6.55
2.68
Revenue
$5,833,958,000.00
$3,094,001,000.00
Revenue This Year
$11.90
$13.39
Revenue Next Year
$10.41
$7.57
P/E Ratio
$25.68
$19.89
Revenue Growth
14.40
12.39
52 Week Low
$148.73
$50.76
52 Week High
$199.99
$73.51

Technical Indicators

Market Signals
Indicator
TXRH
BMRN
Relative Strength Index (RSI) 48.98 46.21
Support Level $164.51 $52.55
Resistance Level $178.68 $54.33
Average True Range (ATR) 3.14 1.24
MACD -0.41 -0.17
Stochastic Oscillator 24.93 19.23

Price Performance

Historical Comparison
TXRH
BMRN

About TXRH Texas Roadhouse Inc.

Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: